HEALTHCARE (NY:XLV)

184.04 +4.32 (+2.40%)

Official Closing Price Updated: 8:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2 3 4 5 6 7 8 9

...

44 45 Next >

Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now ↗

February 11, 2026

Healthcare stocks have lagged the market for years, but 2026 is looking much better.

Via The Motley Fool

5 Stocks and ETFs to Help Shield Your Portfolio During Volatility ↗

February 09, 2026

Via MarketBeat

Topics ETFs

LLY Stock Climbs Pre-Market On $2.4 Deal To Acquire Orna Therapeutics ↗

February 09, 2026

The acquisition will strengthen Lilly’s pipeline with a new class of therapies built on engineered circular RNA and proprietary lipid nanoparticles.

Via Stocktwits

Harel Insurance Sold $330 Million of Invesco KBW Bank ETF ↗

February 05, 2026

Invesco KBW Bank ETF tracks a benchmark of major U.S. banking institutions, offering targeted sector exposure and a moderate yield.

Via The Motley Fool

Topics ETFs Regulatory Compliance

BSX Stock Tumbles Pre-Market On Softer 2026 Sales Growth Forecast ↗

February 04, 2026

Via Stocktwits

Janux Stock Is Rising Pre-Market After A New Oncology Deal With Bristol Myers Squibb ↗

January 22, 2026

Via Stocktwits

TG Therapeutics Stock Pops As Briumvi Boom Reignites Bull Case: Goldman Sachs Sees Room For 32% Rally ↗

January 15, 2026

Via Stocktwits

UNH Stock Craters To 6-Month Low: Piper Sandler Still Sees 40% Upside, Would Buy The Dip ↗

January 28, 2026

UnitedHealth expects some membership contraction in 2026 and noted that CMS’s Medicare rate “simply doesn't reflect the reality.”

Via Stocktwits

ALT Stock Surges Toward Sixth Straight Day Of Gains: Retail Bets A Buyout Is On The Horizon ↗

January 27, 2026

Altimmune plans to raise $75 million via a direct offering to bankroll its Phase 3 MASH trial, easing near-term funding risk.

Via Stocktwits

INMD Stock Jumped Nearly 13% Today – What’s Powering The Rally? ↗

January 26, 2026

According to a Calcalist report, the company is set to go private after a $1.1 billion acquisition by a fund.

Via Stocktwits

Topics Artificial Intelligence

Revolution Medicines Stock Stares At Big Dip After Merck Reportedly Shelves Buyout — But Analyst Flags Opportunity ↗

January 26, 2026

Stifel expects dip-buyers to step in, saying it would be surprised to see RVMD settle meaningfully below $100, calling the failed talks an “M&A clearing event.”

Via Stocktwits

The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare

January 23, 2026

The healthcare landscape underwent a seismic shift in 2024, as the industry’s major players pivoted away from traditional hardware toward high-margin diagnostic platforms and artificial intelligence...

Via MarketMinute

Topics Artificial Intelligence Economy

BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? ↗

January 12, 2026

Via Stocktwits

Why Did Corcept Therapeutics Stock Surge Over 14% Today? ↗

January 22, 2026

In the ROSELLA trial, patients receiving relacorilant with nab-paclitaxel saw their risk of death drop by about 35% compared with those given the chemotherapy alone.

Via Stocktwits

Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗

January 16, 2026

ARK doubles down on a CRISPR bet as Intellia Therapeutics’ stock heads for its best week since October.

Via Stocktwits

Topics Artificial Intelligence ETFs

Nano-Cap Regentis Biomaterials Stock Is Up Nearly 15% This Year: Why Retail Traders Are Swarming It ↗

January 16, 2026

Heading to close this week as its best week since IPO, RGNT has become a retail favorite with surging followers on Stocktwits.

Via Stocktwits

Topics Initial Public Offering Intellectual Property

MLTX Stock Erases Most Of 2025 Loses As Wall Street, Retail Bets On FDA Feedback For Sonelokimab ↗

January 15, 2026

The FDA said that the drug, which treats a chronic inflammatory skin disorder, could establish evidence without additional trials.

Via Stocktwits

Is Molina Healthcare The Next GEICO? Michael Burry Feels It's A ‘Special One’ ↗

December 31, 2025

Via Stocktwits

Retail Traders Are Piling Into TG Therapeutics – What’s Driving The Chatter? ↗

January 14, 2026

On Tuesday, the company provided the revenue outlook for 2026 and fourth-quarter (Q4) and fiscal year 2025 revenue projection for BRIUMVI.

Via Stocktwits

Topics Artificial Intelligence

Ventyx’s $1.2B Buyout By Eli Lilly Proves Timing Often Beats Conviction In Biotech Investing — A VC Explains ↗

January 07, 2026

Bottom buyers saw over 2,000% gains, while IPO investors merely broke even after a 90% drawdown, according to Atlas Venture’s Bruce Booth.

Via Stocktwits

Topics Initial Public Offering

The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026

January 06, 2026

As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence...

Via MarketMinute

Topics Artificial Intelligence Economy Government

The Great Rebalancing: Tech Giants Retreat as Investors Pivot to Defensive Safety in 2025's Final Days

December 29, 2025

As the curtain closes on 2025, the "Great Rebalancing" has taken center stage in the financial markets. On this December 29, 2025, the dominant narrative that fueled triple-digit gains for AI-centric...

Via MarketMinute

Topics Artificial Intelligence Economy World Trade

Sector Rotation: 2 Smart Money Moves for 2026 ↗

December 26, 2025

Via MarketBeat

Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors? ↗

December 24, 2025

This basket of 64 medical device stocks could raise its dividend for decades.

Via The Motley Fool

Topics ETFs Government Supply Chain

S&P 500 Stumbles as Mixed Jobs Report Fuels Fed Speculation, Ford Axes F-150 Lightning in Major EV Pivot

December 16, 2025

The U.S. stock market experienced a notable downturn on Tuesday, December 16, 2025, with the S&P 500 leading the retreat, following the release of a November jobs report that presented a complex and...

Via MarketMinute

Topics Economy Electric Vehicles Energy

The Top 3 Investment Themes That Will Dominate 2026 ↗

December 10, 2025

Via MarketBeat

5 Healthcare Names to Watch as Sector Rotation Is in Full Swing ↗

December 01, 2025

Via MarketBeat

Tech Stocks Fall Despite Nvidia's Beat, Walmart Jumps 6%: What's Moving Markets Thursday? ↗

November 20, 2025

Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lift Wall Street on Thursday.

Via Benzinga

Interest Rate Hikes: A Looming Threat or Hidden Opportunity for the Stock Market?

November 19, 2025

As of mid-November 2025, the financial markets are grappling with a pervasive sense of uncertainty, primarily driven by the persistent specter of elevated interest rates. The "higher for longer"...

Via MarketMinute

Topics Economy Stocks

Tech Edges Up Ahead Of Nvidia's Earnings, Bitcoin Sinks Below $90,000: What's Moving Markets Wednesday? ↗

November 19, 2025

All eyes are on Nvidia Corp. (NASDAQ:NVDA) as the world's most valuable company prepares to report third-quarter earnings after the close, a pivotal moment that could steer

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

44 45 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.